DOI QR코드

DOI QR Code

Photobiomodulation and Miescher's cheilitis granulomatosa: case report

  • Porrini, Massimo (Department of Biomedical, Surgical and Dental Sciences-Maxillo-Facial and Odontostomatology Unit-Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda, University of Milan) ;
  • Garagiola, Umberto (Department of Biomedical, Surgical and Dental Sciences-Maxillo-Facial and Odontostomatology Unit-Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda, University of Milan) ;
  • Rossi, Margherita (Department of Biomedical, Surgical and Dental Sciences-Maxillo-Facial and Odontostomatology Unit-Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda, University of Milan) ;
  • Bosotti, Moreno (Department of Biomedical, Surgical and Dental Sciences-Maxillo-Facial and Odontostomatology Unit-Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda, University of Milan) ;
  • Marino, Sonia (Department of Biomedical, Surgical and Dental Sciences-Maxillo-Facial and Odontostomatology Unit-Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda, University of Milan) ;
  • Gianni, Aldo Bruno (Department of Biomedical, Surgical and Dental Sciences-Maxillo-Facial and Odontostomatology Unit-Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda, University of Milan) ;
  • Runza, Letterio (Division of Pathology, Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda, University of Milan) ;
  • Spadari, Francesco (Department of Biomedical, Surgical and Dental Sciences-Maxillo-Facial and Odontostomatology Unit-Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda, University of Milan)
  • Received : 2020.08.20
  • Accepted : 2020.10.04
  • Published : 2020.12.31

Abstract

Background: Miescher's cheilitis granulomatosa (MCG) is a rare chronic inflammatory disease and is known as the monosymptomatic clinical form of Melkersson-Rosenthal syndrome (MRS). It is characterised by swelling of one or both lips and more frequently affects the upper lip. Histopathological findings show the presence of numerous inflammatory infiltrates and granuloma formations. Pharmacological treatments and surgery have provided results that are positive yet insufficiently stable in the long term. The clinical case described is of a 68-year-old female patient with a diagnosis of MCG of the upper lip. Case presentation: The patient was diagnosed and treated at the Oral Medicine and Oral Pathology outpatient clinic of Maxillofacial and Odontostomatology Unit, Fondazione Cà Granda IRCCS Ospedale Maggiore Policlinico. The patient was recommended localised treatments of photobiomodulation (PBM) using a diode laser with a 635 nm and 980 nm dual-wavelength (λ) approach, a 600-micron fibre, and a handpiece with a 1-cm-diameter lens at 300 mW. Three treatments a week were administered for four weeks for a total of 12 treatment sessions (T1-T12). After that, the patient had a long follow-up period of about 2 years. The therapeutic results were clear from the initial stages of treatment. There was an immediate, gradual, and consistent reduction in labial swelling. A reduction in the size of the lip by about 35% at T10-T12 was observed, returning the size and volume of the upper lip within the normal clinical range. The painful symptoms subsided after the seventh treatment (T7). The histopathological check at 3 months and the follow-up in particular confirmed the disease was in remission with satisfactorily stable treatment results. Moreover, the patient did not use any other treatments on the area from the early laser treatments through to the end of the follow-up period. Conclusions: Our experience describes a clinical case of MCG treated with PBM and effectively resolved with a reduction of the lip swelling. The real success of the treatment emerged over time, showing that the tissue healing was stable. In absence of any collateral phenomena, this confirms the effective and documented therapeutic potential of PBM for chronic inflammatory infiltrates.

Keywords

References

  1. McCartan BE, Healy CM, McCreary CE, Flint SR, Rogers S, Toner ME (2011) Characteristics of patients with orofacial l granulomatosis. Oral Dis 17:696-704
  2. Jain R, Yadav D, Puranik N, Guleria R, Jin JO (2020) Sarcoidosis: Causes, diagnosis, clinical features, and treatments. J Clin Med 9:1081
  3. Terziroli Beretta-Piccoli B, Mainetti C, Peeters MA, Laffitte E (2018) Cutaneous granulomatosis: a Comprehensive review. Clin Rev Allergy Immunol 54:131-146
  4. Shah KK, Pritt BS, Alexander MP (2017) Histopathologic review of granulomatous inflammation. J Clin Tuberc Other Mycobact Dis 7:1-12
  5. Troiano G, Dioguardi M, Giannatempo G, Laino L, Testa NF, Cocchi R et al (2015) Orofacial granulomatosis: clinical signs of different pathologies. Med Princ Pract 24:117-122
  6. Al-Hamad A, Porter S, Fedele S (2015) Orofacial Granulomatosis. Dermatol Clin. J 33:433-446
  7. Miest R, Bruce A, Rogers RS 3rd (2016) Orofacial granulomatosis. Clin Dermatol 113:505-513
  8. Marcoval J, Penin RM (2016) Histopathological features of orofacial granulomatosis. Am J Dermatopathol 38:194-200
  9. Miescher G (1945) uber die essentielle granulomatose Makrocheilie (granulomatose Cheilitis). Dermatologica (Basel) 91:57-64
  10. Sciubba JJ, SN AI-N (2003) Orofacial granulomatosis: presentation, pathology and management of 13 cases. J Oral Pathol Med 32:576-585
  11. Wehl G, Rauchenzauner M (2018) A systematic review of the literature of the three related disease entities cheilitis granulomatosa, orofacial granulomatosis and Melkersson-Rosenthal Syndrome. Curr Pediatr Rev 14:196-203
  12. van der Waal RIF, Schulten EAJM, van der Meij EH, van de Scheur MR, Starink TM, van der Waal I (2002) Cheilitis granulomatosa: overview of 13 patients with long-term follow-up: results of management. Int J Dermatol 41:225-229
  13. Dhawan SR, Saini AG, Singhi PD (2020) Management strategies of Melkersson-Rosenthal syndrome: A review. Int J Gen Med 13:61-65
  14. Grave B, McCullough M, Wiesenfeld D (2009) Orofacial granulomatosis-a 20-year review. Oral Dis 15:46-51
  15. Krutchkoff D, James R (1978) Cheilitis granulomatosa. Successful treatment with combined local triancinolone injections and surgery. Arch Dermatol 114:1203-1206
  16. Ezzati K, Fekrazad R, Raoufi Z (2019) The effects of photobiomodulation therapy on post-surgical pain. J Lasers Med Sci 10:79-85
  17. Sommer AP (2019) Revisiting the photon/cell interaction mechanism in low-level light therapy. Photobiomodul Photomed Laser Surg 37:336-341
  18. Sakurai Y, Yamaguchi M, Abiko Y (2000) Inhibitory effect of low- level laser irradiation on LPS-stimulated prostaglandin E2 production and cyclooxygenase-2 in human gingival fibroblasts. Eur J Oral Sci 108:29-34
  19. Aimbire F, Albertini R, Pacheco MT, Castro-Faria-Neto HC, Leonardo PS, Iversen VV et al (2006) Low-level laser therapy induces dose-dependent reduction of TNFalpha levels in acute inflammation. Photomed Laser Surg 24:33-37
  20. Kipshidze N, Nikolaychik V, Keelan MH, Shankar LR, Khanna A (2001) Kornowski R (2001) Low-power helium: neon laser irradiation enhances production of vascular endothelial growth factor and promotes growth of endothelial cells in vitro. Lasers Surg Med. 28:355-364
  21. Bombeccari GP, Garagiola U, Candotto V, Pallotti F, Carinci F, Gianni AB, Spadari F (2018) Diode laser surgery in the treatment of oral proliferative verrucous leukoplakia associated with HPV-16 infection. Maxillofac Plast Reconstr Surg. 40:16